Últimas noticias sobre Impact BioMedical (AMEX:IBO) Bolsa

Impact BioMedical

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.

Impact BioMedical Inc

International Bancshares Corporation - Common Stock

International Bancshares Corp

UNIVERSAL IBOGAINE INC by Universal Ibogaine Inc.

Universal Ibogaine Inc

INDUSTRIAL BK KOREA S/GDR by Industrial Bank of Korea

Industrial Bank of Korea

VanEck Robotics ETF

Catalyst Watch: Microsoft, Meta, and Tesla report, FOMC and a Chinese New Year wildcard

AAPL

ABBV

ANET

BBAI

BBNX

BYND

CCIR

CDMO

DXPE

INTC

JBLU

JBSAY

LEVI

MAMO

MBLY

MSFT

NVDA

PEPG

QUBT

SBUX

SDST

SUUN

TMUS

TSLA

ZIVO

Biotech

Press Releases

General

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

News

IPOs

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

Management

Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

Legal

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

Positioned for Growth: Impact BioMedical Inc.'s (NYSEAmerican: IBO) Push into Cancer and Immune Health

Impact BioMedical Inc. (NYSEAmerican: IBO): Targeting Chronic Diseases with Patented Breakthroughs

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

Impact BioMedical Inc. to Present at The Microcap Conference

PRPH

Athira Pharma

Aytu BioPharma

Biofrontera

Cara Therapeutics

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cingulate

Cocrystal Pharma

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Dare Bioscience

Durect

Gelteq

IGC Pharma

Jaguar Health

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lipocine

Lyra Therapeutics

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

Marinus Pharmaceuticals, Inc. - Common Stock

Marinus Pharma

ProPhase Labs

Pulmatrix

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Talphera

Traws Pharma

TherapeuticsMD

Comments

Impact BioMedical

Noticias

Últimas noticias sobre Impact BioMedical (AMEX:IBO) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL